3.9. Analysis.
Comparison 3 Any antiglucocorticoid versus placebo as adjunct to combination treatment, Outcome 9 Mental state: 2f. Specific ‐ depression ‐ average endpoint scores (CDSS/HAMD total, high score = poor, skewed data).
| Mental state: 2f. Specific ‐ depression ‐ average endpoint scores (CDSS/HAMD total, high score = poor, skewed data) | ||||
|---|---|---|---|---|
| Study | Intervention | Mean | SD | N |
| DHEA | ||||
| Strous 2003 | DHEA | 4.1 | 4.5 | 15 |
| Strous 2003 | Placebo | 5.6 | 4.5 | 12 |
| ketoconazole | ||||
| Marco 2002 | Ketoconazole | 16.0 | 9.2 | 8 |
| Marco 2002 | Placebo | 23.0 | 6.9 | 7 |
| mifepristone | ||||
| Gallagher 2005 | Mifepristone | 7.6 | 6.4 | 10 |
| Gallagher 2005 | Placebo | 8.7 | 9.7 | 10 |